At Cetero, we value the collaborative research conducted at each of our sites with leading pharmaceutical, biotech and generic companies. This Scientific Exchange between industry thought leaders, provides an open forum for the healthcare industry to benefit for our collective expertise.
More than 25 years of experience in clinical research and development has taught us many things—most importantly that collaboration, information and education enable our industry to flourish and benefit the scientific community as a whole.
Please select the appropriate Scientific Exchange link for recent news from Cetero Research.
Publications
Use of Excised Human Skin to Assess the Bioequivalence of Topical Products T.J. Franz P.A. Lehman and S.G. Raney Published in the August 26, 2009 online issue of Skin Pharmacology and Physiology
The Cadaver Skin Absorption Model and the Drug Development Process*
Thomas J. Franz, MS, MD, Paul A. Lehman, MS and Sam G. Raney, PhD Published in the September-October 2008 issue of Pharmacopeial Forum
Stop Costly Phase III Failures
Murray P. Ducharme, PharmD, FCCP, FCP Published as a supplement to the June 2009 Issue of Applied Clinical Trials
30th Anniversary of the Franz Cell Finite Dose Model: The Crystal Ball of Topical Drug Development Sam Raney, PhD; Paul Lehman, MSc; and Thomas Franz, MD Published in the July/August 2008 Issue of Drug Delivery Technology®
From Process to Project Dramatic changes in the way trials are conducted are rapidly expanding the role and skillsets demanded of data managers.
Denise Redkar-Brown, Colleen Cox and Sharon Kayne Chaplock Published in the April 2008 issue of GCPj
Pharmacodynamic Equivalence of Two Orlistat Capsule Formulations in Healthy Volunteers Under Fed Conditions
DiMarco M, Marier JF, Ducharme MP, Morin I, Engel C, Gulbranson S, Thudi NR, Murpani D, Rampal A, Koundinya TS, Deo K, Monif T Published in Int J Clin Pharmacol Ther 2008;46(6):319-326
Use of Freund’s Complete Adjuvant (FCA) in Inflammatory Pain Models: Consequences on the Metabolism and Pharmacokinetics of the Non-peptidic Delta Receptor Agonist SNC80 in the Rat
Projean D, Lessard E, Ducharme MP, Ducharme J Published in Xenobiotica 2007 Aug;37(8):870-83
Phase I Dose Escalation Pharmacokinetic Study in Healthy Volunteers of Resveratrol, a Potential Cancer Chemopreventative Agent
Boocock DJ, Faust GES, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP, Brenner DE Published in Cancer Epidemiol Biomarkers Prev 2007 Jun;16(6):1246-52
Review of Clinical Pharmacokinetics, 4th edition
Seng Yue C, Ducharme MP Published in Ann Pharmacother 2008;42:1352
Book Chapters
Généralités sur les antibiotiques: classification, mécanismes d’action, spectre d’activité, prévention de l’iatropathologie
Ducharme MP Published in: Calop J, ed. Pharmacie Clinique et Thérapeutique. Paris: Editions Masson, 2008. Pages 907-934
Principes d’utilisation des antibiotiques
Ducharme MP Published in: Calop J, ed. Pharmacie Clinique et Thérapeutique. Paris: Editions Masson, 2008. Pages 935-958
Population PK Approaches for Assessing Bioequivalence
Colucci P, Marier JF, Ducharme MP Published in; Kanfer I, Shargel L , eds. Generic Drug Product Development – Bioequivalence Issues. Informa Healthcare, 2007. Pages 143-170
Bioequivalence Assessment of Endogenous Drug Substances: Pharmacokinetics and Statistical Evaluation
Colucci P, Pasternyk DiMarco M, Potvin D, Ducharme MP. Published in: Kanfer I, Shargel L, eds. Generic Drug Product Development – Bioequivalence Issues. Informa Healthcare, 2007. Pages 233-256
